The landscape of patients with metastatic breast cancer enrolled in phase I trials

被引：0
|
作者：
Marra [1 ]
Criscitiello, C. [2 ]
Morganti, S. [1 ]
Zagami, P. [1 ]
Viale, G. [1 ]
Tarantino, P. [1 ]
Trapani, D. [1 ]
Nicolo, E. [1 ]
Repetto, M. [1 ]
Ferraro, E. [1 ]
D'Amico, P. [1 ]
Locatelli, M. [2 ]
Esposito, A. [2 ]
Curigliano, G. [1 ]
机构：
[1] Univ Milan, European Inst Oncol IRCCS, Dept Oncol & Haematooncol, Div Early Drug Dev Innovat Therapies,IEO, Milan, Italy
[2] European Inst Oncol IRCCS, IEO, Div Early Drug Dev Innovat Therapies, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.03.251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
151P
引用
收藏
页码：S70 / S71
页数：2
相关论文
共 50 条
  • [21] Psychological distress in patients with metastatic cancer enrolling on phase I clinical trials
    Alexandra Hunt
    Elizabeth Handorf
    Matthew Blau
    Yana Chertock
    Carolyn Fang
    Michael J Hall
    Rishi Jain
    Journal of Cancer Survivorship, 2021, 15 : 398 - 402
  • [22] Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer
    Goldstein, Lori J.
    BREAST CARE, 2008, 3 : 25 - 28
  • [23] Analysis of Lung Cancer Patients Enrolled in CTEP (Cancer Therapy Evaluation Program)-Sponsored Phase I Trials
    Gadgeel, Shirish M.
    Ivy, Percy
    Chen, Wei
    Mauer, Joan
    Smith, Daryn
    LoRusso, Patricia
    CLINICAL LUNG CANCER, 2011, 12 (04) : 218 - 223
  • [24] Characteristics and outcome of pediatric patients enrolled in phase I oncology trials
    Kim, AeRang
    Fox, Elizabeth
    Warren, Katherine
    Blaney, Susan M.
    Berg, Stacey L.
    Adamson, Peter C.
    Libucha, Madeleine
    Byrley, Elena
    Balis, Frank M.
    Widemann, Brigitte C.
    ONCOLOGIST, 2008, 13 (06): : 679 - 689
  • [25] Characteristics and outcomes of patients enrolled in the CORRECT and CONCUR phase 3 trials of regorafenib for metastatic colorectal cancer (mCRC)
    Vogel, A.
    van Cutsem, E.
    Wagner, A.
    Kalmus, J.
    Qin, S.
    Kim, T. W.
    Li, J.
    Xu, R.
    Grothey, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 71 - 71
  • [26] Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre
    Brent O’Carrigan
    Joline Si Jing Lim
    Awais Jalil
    Samuel John Harris
    Dionysis Papadatos-Pastos
    Udai Banerji
    Juanita Lopez
    Johann Sebastian de Bono
    Timothy Anthony Yap
    British Journal of Cancer, 2018, 119 : 922 - 927
  • [27] Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre
    O'Carrigan, Brent
    Lim, Joline Si Jing
    Jalil, Awais
    Harris, Samuel John
    Papadatos-Pastos, Dionysis
    Banerji, Udai
    Lopez, Juanita
    de Bono, Johann Sebastian
    Yap, Timothy Anthony
    BRITISH JOURNAL OF CANCER, 2018, 119 (08) : 922 - 927
  • [28] The genomic landscape of 501 metastatic breast cancer patients
    Angus, L.
    Wilting, S. M.
    van Riet, J.
    Smid, M.
    Steenbruggen, T. G.
    Tjan-Heijnen, V. C.
    Labots, M.
    van Riel, J. M.
    Bloemendal, H. J.
    Steeghs, N.
    van de Werken, H. J.
    Lolkema, M. P.
    Voest, E. E.
    Jager, A.
    Cuppen, E.
    Sleijfer, S.
    Martens, J. W.
    CANCER RESEARCH, 2019, 79 (04)
  • [29] EVOLUTION AND LANDSCAPE OF CLINICAL TRIALS FOR BREAST CANCER PATIENTS
    Dogan, S.
    Goubar, A.
    Arnedos, M.
    Delaloge, S.
    Andre, F.
    ANNALS OF ONCOLOGY, 2012, 23 : 47 - 47
  • [30] Use of the Pallia 10 score in patients enrolled in phase I trials at Gustave Roussy Cancer Center
    Ouali, Kaissa
    Mateus, Christine
    Laparra, Ariane
    Pavliuc, Elena
    Romano, Patricia Martin
    Sampetrean, Anda
    Varga, Andrea
    Champiat, Stephane
    Verlingue, Loic
    Geraud, Arthur
    Marabelle, Aurelien
    Hollebecque, Antoine
    Gazzah, Anas
    Bahleda, Rastilav
    Postel-Vinay, Sophie
    Ribrag, Vincent
    Soria, Jean-Charles
    Scotte, Florian
    Massard, Christophe
    Baldini, Capucine
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
12345